Notice to the Market
Belo Horizonte, December 2, 2016 – CENTRO DE IMAGEM DIAGNÓSTICOS S.A. (BM&FBOVESPA Ticker: AALR3) (“Alliar” or “Company”), hereby informs its shareholders and the market in general that, as approved by its Board of Directors, its Financial Statements for the periods of 3, 6 and 9 months ended on March 31, 2016, June 30, 2016, September 30, 2016, respectively, and the years ended on December 31, 2015 and December 31, 2014, were restated on this date.
The restatements were necessary due to a relocation in the amounts of the exchange rate variation between the years of 2014 and of 2015 and the correction in the exchange rate for the first 2 quarters of 2015.
The corrections had an impact in the Financial Statements, in the comprehensive result, in the cash flows, in the alterations of the equity and in the added value, as well as in Notes 19 (earnings per share), 22 (financial result) and 23 (income tax and social contribution) of the Financial Information for the 1st, 2nd and 3rd quarter of 2016 (changing only the 2015 numbers used for comparisons). In the 2015 and 2014 years, in addition to these impacts, Notes 15 (Loans and Financing) and 25 (Financial Instruments) were also amended.
On the occasion of these restatements, the Company chose to also carry out corrections on the non-material information in Notes 10 (investments in subsidiaries) and 21 (details of the nature of the costs and expenses), in the statements of the equity‘s alterations and reallocations between the lines in the cash flow statement for the 1st and 2nd quarter of 2015, without changing the net cash generation of these periods nor the cumulative cash flow statement for the 9 months of 2015.
Carlos Thiago de Souza Araujo
Investor Relations Officer